Free Trial

PetVivo (PETV) Competitors

PetVivo logo
$0.56 0.00 (0.00%)
As of 04/17/2025

PETV vs. EDAP, SURG, ICAD, GUTS, TMDIF, APT, ECOR, APYX, TELA, and OM

Should you be buying PetVivo stock or one of its competitors? The main competitors of PetVivo include Edap Tms (EDAP), SurgePays (SURG), iCAD (ICAD), Fractyl Health (GUTS), Titan Medical (TMDIF), Alpha Pro Tech (APT), electroCore (ECOR), Apyx Medical (APYX), TELA Bio (TELA), and Outset Medical (OM). These companies are all part of the "medical equipment" industry.

PetVivo vs.

Edap Tms (NASDAQ:EDAP) and PetVivo (NASDAQ:PETV) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, valuation, community ranking, media sentiment, earnings, dividends and risk.

Edap Tms currently has a consensus price target of $8.50, suggesting a potential upside of 515.94%. Given Edap Tms' stronger consensus rating and higher possible upside, equities research analysts clearly believe Edap Tms is more favorable than PetVivo.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Edap Tms
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67
PetVivo
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

In the previous week, Edap Tms had 3 more articles in the media than PetVivo. MarketBeat recorded 4 mentions for Edap Tms and 1 mentions for PetVivo. Edap Tms' average media sentiment score of 0.48 beat PetVivo's score of 0.00 indicating that Edap Tms is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Edap Tms
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
PetVivo
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Edap Tms has a net margin of -34.92% compared to PetVivo's net margin of -902.82%. Edap Tms' return on equity of -44.21% beat PetVivo's return on equity.

Company Net Margins Return on Equity Return on Assets
Edap Tms-34.92% -44.21% -25.88%
PetVivo -902.82%-4,813.07%-281.78%

Edap Tms has a beta of 0.12, meaning that its stock price is 88% less volatile than the S&P 500. Comparatively, PetVivo has a beta of 1.85, meaning that its stock price is 85% more volatile than the S&P 500.

Edap Tms received 349 more outperform votes than PetVivo when rated by MarketBeat users.

CompanyUnderperformOutperform
Edap TmsOutperform Votes
349
60.91%
Underperform Votes
224
39.09%
PetVivoN/AN/A

PetVivo has lower revenue, but higher earnings than Edap Tms. Edap Tms is trading at a lower price-to-earnings ratio than PetVivo, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Edap Tms$64.12M0.80-$22.92M-$0.55-2.51
PetVivo$1.05M12.87-$10.95M-$0.45-1.23

62.7% of Edap Tms shares are owned by institutional investors. Comparatively, 24.5% of PetVivo shares are owned by institutional investors. 0.2% of Edap Tms shares are owned by company insiders. Comparatively, 10.8% of PetVivo shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Edap Tms beats PetVivo on 11 of the 17 factors compared between the two stocks.

Get PetVivo News Delivered to You Automatically

Sign up to receive the latest news and ratings for PETV and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PETV vs. The Competition

MetricPetVivoSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$13.46M$4.07B$5.31B$7.35B
Dividend YieldN/A46.44%5.45%4.29%
P/E Ratio-1.2328.0921.9417.81
Price / Sales12.8747.06380.9597.70
Price / CashN/A51.0838.2634.64
Price / Book-18.525.816.453.98
Net Income-$10.95M$67.09M$3.22B$247.81M
1 Month Performance1.22%-11.64%-9.76%-7.91%
1 Year Performance-24.39%14.55%11.49%1.53%

PetVivo Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PETV
PetVivo
N/A$0.56
flat
N/A-22.8%$13.46M$1.05M-1.2320
EDAP
Edap Tms
2.5539 of 5 stars
$1.38
-2.8%
$8.50
+515.9%
-80.6%$51.20M$64.12M-2.12230Short Interest ↑
Gap Up
SURG
SurgePays
2.6056 of 5 stars
$2.47
+9.8%
$8.50
+244.1%
-33.2%$50.42M$60.88M-2.1940Short Interest ↑
ICAD
iCAD
0.3218 of 5 stars
$1.82
+2.2%
N/A+102.5%$49.81M$19.61M-14.00140Analyst Downgrade
Short Interest ↑
News Coverage
Gap Up
GUTS
Fractyl Health
1.7173 of 5 stars
$0.99
-1.5%
$10.00
+905.3%
-81.4%$48.66M$93,000.00-0.08102Analyst Forecast
News Coverage
TMDIF
Titan Medical
N/A$0.41
-3.1%
N/A+776.2%$46.51M$17.63M-0.3350Gap Up
APT
Alpha Pro Tech
N/A$4.25
+2.2%
N/A-27.8%$46.21M$57.84M11.49120
ECOR
electroCore
3.196 of 5 stars
$5.88
+5.6%
$25.50
+333.7%
+6.7%$42.30M$25.18M-3.2150News Coverage
Positive News
APYX
Apyx Medical
1.2605 of 5 stars
$1.07
+11.7%
N/A-28.3%$40.44M$48.10M-1.29270News Coverage
TELA
TELA Bio
1.9572 of 5 stars
$1.01
+3.2%
$7.25
+617.8%
-81.4%$39.78M$69.30M-0.60120Short Interest ↑
Gap Up
OM
Outset Medical
1.1282 of 5 stars
$11.06
+8.9%
$35.00
+216.5%
-67.4%$39.76M$113.69M-4.46520High Trading Volume

Related Companies and Tools


This page (NASDAQ:PETV) was last updated on 4/19/2025 by MarketBeat.com Staff
From Our Partners